Double-Blind Study of Miglitol in Japanese With type2 Diabetes

Sanwa Kagaku Kenkyusho

Status and phase: Completed; Phase 3

Conditions: Type 2 Diabetes Mellitus

Treatments: Drug: miglitol

Study type: Interventional

Funder types: Industry

Identifiers

NCT00380822

MG1001

Details and patient eligibility

About

To investigate the efficacy and safety of miglitol in Japanese patients with type 2 diabetes that is insufficiently controlled diet alone.

Sex: All

Ages: 20 to 69 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Type2 diabetic patient on Dietary Therapy
• Criteria for postprandial plasma glucose and HbA1c are met

Exclusion criteria

• Type1 diabetes
• Patients treated with antidiabetic drugs or Insulin

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind